Condition: Peripheral Artery Disease · Heart Failure · Sponsor: Tartu University Hospital
Single centre observational study to assess lower extremity arterial disease (LEAD) patients' cardiac dysfunction with strain analyses and to assess connections between cardiac dysfunction, metabolomic changes and target organ damage in LEAD.
This description comes directly from the study's public registry record.
Jaak Kals, PhD · 731 8292 · jaak.kals@ut.ee
Always discuss trial participation with your own doctor first.
| Tartu University Hospital | Tartu, Estonia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06215248